Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Applied Therapeutics Inc. (APLT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/16/2022 |
4/A
| MARCUS JOEL S (Director) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Exercised 13,071 shares
@ $10, valued at
$130.7k
Exercised 35,911 shares
@ $4.7, valued at
$168.8k
Exercised 13,071 options to buy
@ $10, valued at
$130.7k
|
|
| 01/11/2022 |
4/A
| Silberstein Charles (CFO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 47,900 shares
@ $0 |
|
| 01/11/2022 |
4/A
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 120,900 shares
@ $0 |
|
| 01/11/2022 |
4/A
| Perfetti Riccardo (Chief Medical Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 48,200 shares
@ $0 |
|
| 01/11/2022 |
4/A
| Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 31,700 shares
@ $0 |
|
| 05/29/2019 |
4/A
| Shendelman Shoshana (President and CEO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Converted 88,397 shares
@ $0
Converted 88,397 preferred shares
@ $0 |
|
|
|